support@shashwatpublication.com +91 7000072109 B-75, Krishna Vihar, Koni, Bilaspur, C.G 495001
Mon - Sat 10:00 AM to 5:00 PM
Book Image
Book Image
Book Image

ISBN : 978-93-6087-269-4

Category : Academic

Catalogue : Medical And Nursing

ID : SB21729

A Textbook on GENERIC PRODUCT DEVELOPMENT for B. Pharmacy Students

(Comprehensive Guide to Formulation, Evaluation, and Regulatory Aspects)

1.Dr. T. Naga Aparna 2.B. Deepthi 3.Dr. Pittu Vishnu Priya 4.Dr. R. Prasanthi 5.Dr. Perli Kranti Kumar

Paperback

399.00

e Book

179.00

Pages : 106

Language : English

PAPERBACK Price : 399.00

About Book

This book provides a comprehensive insight into the process of generic drug product development, guiding readers through each critical phase from conceptualization to regulatory approval. Developed to align with academic curricula and industrial standards, the text serves as a valuable resource for pharmacy students, regulatory professionals, and formulation scientists. The content is systematically organized into five units, beginning with the historical background and legal framework of generic drug development, including a detailed discussion on the Hatch-Waxman Act and its implications. Subsequent chapters delve into the design and optimization of dosage forms to ensure therapeutic equivalence with reference listed drugs (RLDs), covering aspects such as formulation, process development, and packaging considerations. The book also emphasizes analytical method development for verification and validation at various stages—from raw material to finished dosage forms. It elaborates on stability testing protocols under various environmental conditions to determine product shelf life, and scale-up strategies for manufacturing and exhibit batch execution. A dedicated section is provided on bioequivalence study design, regulatory criteria, and in-vitro techniques used to demonstrate bioequivalence. Further, the book introduces the electronic Common Technical Document (eCTD), detailing its modular structure and significance in regulatory submissions. The final unit explores the drug approval process in both India and the United States, offering comparative insights for global regulatory compliance. Key Features: • Covers the complete lifecycle of generic drug development • Integrates formulation science, quality assurance, and regulatory affairs • Includes discussion on global regulatory systems with a focus on USFDA and CDSCO • Provides foundational knowledge and practical strategies for dossier preparation and submission This book equips readers with the necessary knowledge and tools to effectively contribute to the generic pharmaceutical industry, ensuring quality, efficacy, and regulatory compliance in drug development projects.


About Author

This book is the collaborative effort of five accomplished academicians and researchers, each bringing their unique expertise and experience to the development of this comprehensive text on generic drug product development. Dr. T. Naga Aparna, with her extensive academic and research background in pharmaceutics, has played a key role in conceptualizing the overall structure of the book. Her insights into formulation design, stability studies, and dossier preparation have greatly enriched the depth and clarity of the content. She also led the editorial review process to ensure scientific rigor and academic quality. B. Deepthi contributed significantly to the sections related to dosage form development, analytical chemistry, and method validation. Her academic excellence and focused research in pharmaceutical chemistry helped shape the content to be both precise and practically relevant for students and professionals alike. Dr. Pittu Vishnu Priya brought her specialization in pharmaceutical biotechnology and her experience with regulatory submissions to the chapters on bioequivalence, scale-up studies, and the eCTD framework. Her contributions ensured that the book addresses both scientific and regulatory dimensions in a balanced manner. Dr. R. Prasanthi drew from her industry and academic background to contribute to the chapters on stability testing and exhibit batch execution. Her inputs bridged the gap between theoretical knowledge and practical implementation, enhancing the book’s real-world applicability. Dr. Perli Kranti Kumar, known for his expertise in analytical method development and regulatory affairs, contributed extensively to the sections on analytical validation, impurity profiling, and global drug approval processes. His guidance ensured that the content meets both academic and industrial standards, aligning with current regulatory expectations. Together, the authors have combined their strengths to develop a well-structured and informative resource that supports students, educators, and pharmaceutical professionals in understanding and applying the principles of generic drug product development and regulatory compliance.

Customer Reviews


 

Book from same catalogue